SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $200,000 | -10.3% | 6,198 | -14.3% | 0.02% | +5.9% |
| Q2 2021 | $223,000 | +10.4% | 7,230 | -6.4% | 0.02% | +6.2% |
| Q1 2021 | $202,000 | -46.3% | 7,727 | -28.0% | 0.02% | -46.7% |
| Q1 2019 | $376,000 | +36.7% | 10,735 | +71.3% | 0.03% | +76.5% |
| Q3 2018 | $275,000 | -69.1% | 6,266 | -57.8% | 0.02% | -68.5% |
| Q2 2018 | $890,000 | +256.0% | 14,863 | +172.7% | 0.05% | +315.4% |
| Q1 2018 | $250,000 | -32.6% | 5,451 | -36.7% | 0.01% | -38.1% |
| Q2 2017 | $371,000 | – | 8,607 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |